{"product_id":"quantitative-evaluation-of-safety-in-drug-development-practical","title":"Quantitative Evaluation of Safety in Drug Development - Practical","description":"\u003cp\u003eIn this review of Quantitative Evaluation of Safety in Drug Development, the authors provide a targeted resource for statisticians and safety scientists who need rigorous, applied methods for drug safety assessment. The single biggest reason to buy this book is its focus on practical, up-to-date statistical techniques for both trial design and post-marketing safety evaluation, making it useful for teams navigating regulatory and industry scrutiny. The review finds the text strong on methodological breadth and clear on how to apply methods in real development programs.\u003c\/p\u003e\n\n\u003ch2\u003eKey Features\u003c\/h2\u003e\n\u003cul\u003e\n \u003cli\u003e\n\u003cstrong\u003eComprehensive coverage:\u003c\/strong\u003e Addresses study design, safety monitoring, and data evaluation to guide safety assessment across development stages.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eModern statistical methods:\u003c\/strong\u003e Presents Bayesian approaches and other up-to-date techniques that improve risk quantification and decision making.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003ePractical graphics guidance:\u003c\/strong\u003e Recommends effective safety graphics that help communicate complex safety profiles to regulators and teams.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eRegulatory relevance:\u003c\/strong\u003e Discusses challenges and expectations across regulatory agencies, industry, and academia to help align analyses with review standards.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eRisk-benefit focus:\u003c\/strong\u003e Covers quantitative approaches to risk-benefit evaluation so readers can weigh harms and benefits in development decisions.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eApplied orientation:\u003c\/strong\u003e Emphasizes implementation in clinical trials and observational studies rather than only theory.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eWho It's For\u003c\/h2\u003e\n\u003cp\u003eQuantitative Evaluation of Safety in Drug Development is aimed primarily at biostatisticians, pharmacovigilance professionals, and safety scientists working in pharmaceutical development who need actionable methods for designing safety studies and analyzing complex safety data. The book is also suitable for academic researchers focusing on applied probability and statistics in medicine.\u003c\/p\u003e\n\u003cp\u003ePractitioners who want a step-by-step programming manual or a beginner's introduction to basic statistics may want a more elementary textbook; this volume assumes familiarity with statistical concepts and a need for advanced, field-specific techniques.\u003c\/p\u003e\n\n\u003ch2\u003ePros \u0026amp; Cons\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003ePros\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n \u003cli\u003eThoroughly covers design, monitoring, and analysis, giving a cohesive view of safety assessment across development.\u003c\/li\u003e\n \u003cli\u003eIncorporates \u003cstrong\u003eBayesian methods\u003c\/strong\u003e and modern approaches that are increasingly used in regulatory settings.\u003c\/li\u003e\n \u003cli\u003ePractical advice on \u003cstrong\u003esafety graphics\u003c\/strong\u003e and reporting helps translate analysis into clear regulatory documents.\u003c\/li\u003e\n \u003cli\u003eAddresses cross-sector challenges, making it relevant to industry, regulators, and academia.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCons\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n \u003cli\u003eNot an introductory text; it expects statistical background and can be dense for novices.\u003c\/li\u003e\n \u003cli\u003eContains limited hands-on code or software walkthroughs, so readers must implement methods independently.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n \u003ctr\u003e\n\u003ctd\u003eTitle\u003c\/td\u003e\n\u003ctd\u003eQuantitative Evaluation of Safety in Drug Development\u003c\/td\u003e\n\u003c\/tr\u003e\n \u003ctr\u003e\n\u003ctd\u003eSeries\u003c\/td\u003e\n\u003ctd\u003eChapman \u0026amp; Hall\/CRC Biostatistics Series\u003c\/td\u003e\n\u003c\/tr\u003e\n \u003ctr\u003e\n\u003ctd\u003eAuthors\u003c\/td\u003e\n\u003ctd\u003eQi Jiang, H. Amy Xia\u003c\/td\u003e\n\u003c\/tr\u003e\n \u003ctr\u003e\n\u003ctd\u003eFocus areas\u003c\/td\u003e\n\u003ctd\u003eStudy design, safety monitoring, data evaluation and analysis\u003c\/td\u003e\n\u003c\/tr\u003e\n \u003ctr\u003e\n\u003ctd\u003eKey methods\u003c\/td\u003e\n\u003ctd\u003eBayesian methods, risk-benefit evaluation, safety graphics\u003c\/td\u003e\n\u003c\/tr\u003e\n \u003ctr\u003e\n\u003ctd\u003eIntended use\u003c\/td\u003e\n\u003ctd\u003eClinical trials and observational studies in drug development\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eOur Verdict\u003c\/h2\u003e\n\u003cp\u003eFor statisticians and safety professionals who need a contemporary, applied reference on drug safety, this book delivers valuable methods and context for regulatory and industry work. It is good value for readers who require modern statistical techniques and clear guidance on reporting and graphics, though those new to statistical practice will need supplementary introductory material.\u003c\/p\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eDoes this book cover Bayesian methods?\u003c\/strong\u003e\u003cbr\u003eYes. The book explicitly includes Bayesian approaches as part of its modern toolbox for safety assessment.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eIs the content applicable to observational studies?\u003c\/strong\u003e\u003cbr\u003eYes. The authors address both clinical trials and observational study design and analysis for safety evaluation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWill it teach software implementation?\u003c\/strong\u003e\u003cbr\u003eThe book emphasizes methods and reporting rather than step-by-step software tutorials, so readers should be prepared to implement techniques themselves.\u003c\/p\u003e","brand":"Qi Jiang, H. Amy Xia","offers":[{"title":"Default Title","offer_id":48149468119259,"sku":"1466555459","price":130.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0724\/1043\/1707\/files\/61FIMT9kDOL._SL1360.jpg?v=1768831887","url":"https:\/\/gearmusthave.com\/products\/quantitative-evaluation-of-safety-in-drug-development-practical","provider":"GearMustHave","version":"1.0","type":"link"}